Elotuzumab is an upcoming FDA drug, prescribed for the management of multiple myeloma, one of the complex malignances treated by Hematologists. The commercial reference to Elotuzumab is Empliciti, a brand supplied as 300mg and 400mg vials. Elotuzumab is supposed stored be refrigerated between 2 to 8 Degrees, applicable even during the transit conditions. This product is jointly facilitated by the companies – AbbVie and BMS.
Empliciti 300mg & Empliciti 400mg – FDA and EMA Approvals
Elotuzumab FDA approval was as recent as 2014 as a Breakthrough Therapy, specifically for the management of MM. EMA granted its approval in 2019. Bristol-Myers Squibb is authorized for the marketing of Empliciti, both 300mg and 400mg strengths. They have active distribution in the USA and across the Europe.
- For the advanced treatment of Multiple Myeloma, Elotuzumab is used as a combination drug; lenalidomide and dexamethasone are the two other drugs. Recent updates suggest the benefit of using pomalidomide as part of the combination protocol.
- Clinical experts recommend this drug for relapsed and refractory cases, mostly as a third line treatment option. Lenalidomide based prior treatment is prerequisite for recommending Empliciti. This medication is also prescribed as a second line option. This monoclonal antibody based treatment has the potential of benefiting patients in the first line settings as well. Ongoing clinical research of this drug suggests such a superior impact in terms of prolonged survival.
Elotuzumab India – Accessibility and concerns of availability
Elotuzumab in India is one of the preferred drugs assessed under advanced or alternative protocols. Hematologists counsel their patients for adequate preparedness for procuring Empliciti in India. Such prior notice is important considering the limitations with its access. But, producing this drug is more complex than surfing the basic information like Elotuzumab cost in India. Many patients find this a strenuous process. A simple search for Elotuzumab price in India may not lead to the ideal sources as these products can’t be legally advertized. This is also an apparent policy of Google and other search engines. Therefore, in order to secure authentic access is to talk to the consultants and hospital’s procurement teams regarding Elotuzumab in India. It helps in a way in terms of saving time and gathering sufficient feedback about the suppliers. Elotuzumab price could fluctuate or change with dependencies like currency rates and international shortages.
Procure Elotuzumab in India, stress free
DGCI has designated CDSCO to assist Indian Patients with necessary approvals to import medicines that are not marketed in India. Import Permit for Elotuzumab in India is granted based on recommendation by a registered physician. Patients may contact global suppliers and initiate formal import of Empliciti in India. The procedure may take a couple of weeks. Availability of product and logistics limitations would determine the timelines. Considering all these factors and the advice of treating physicians, it is better to source the medication for the entire treatment. This has the benefit of saving on the expenditure along with preparedness for treatment without any stress or hassle.
Contact Noel Biotech – +91 9677010046 / +91 992977766; firstname.lastname@example.org